Clinical Rationale and Indications for Particle Therapy

Area of Science:

• Medical physics
• Radiation oncology
• Particle physics

Background:

• Particle therapy, including proton and heavy ion radiotherapy, offers physical advantages over photon therapy, such as reduced integral dose.
• Protons exhibit comparable biological effects to photons, while heavier ions like carbon ions provide increased relative biological effectiveness (RBE).
• Children and long-term survivors may particularly benefit due to sensitive normal tissues and the potential for long-term radiation side effects.

Purpose of the Study:

• To summarize the current understanding of ion beam therapy.
• To outline the potential clinical rationales for its use.
• To identify current and potential indications for ion beam therapy.

Main Methods:

• Review of existing clinical studies, primarily retrospective, on proton and heavy ion radiotherapy.
• Analysis of physical and biological properties of particle beams.
• Identification of ongoing and recruiting clinical trials.

Main Results:

• Retrospective studies indicate promising results for various tumor types treated with proton and heavy ion radiotherapy.
• Particle therapy demonstrates a reduction in integral dose compared to conventional photon therapy.
• Heavier charged particles, such as carbon ions, show higher relative biological effectiveness.

Conclusions:

• Ion beam therapy presents a promising advancement in radiation oncology with potential clinical benefits.
• Further clinical trials are essential to fully evaluate the efficacy and prognostic impact of ion beam therapy.
• Proton therapy may offer significant advantages for pediatric patients due to their radiosensitive tissues and long life expectancy.